Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene ...

Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of regRNAs ever compiled, uncovering thousands of previously undiscovered regRNAs in human cells New research enables the ...

[L-R] Baisong Mei, Anna O'Driscoll chat with City Therapeutics CEO Andy Orth. City Therapeutics, a startup whose co-founders include RNA interference drug pioneer John Maraganore, PhD, is building a ...

AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common ...

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced it will present two oral presentations and one poster presentation at the American ...

Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (SLXN) (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today ...

-- Novel approach to gene knockdown uses proprietary CASi (Conditionally Activated siRNA) molecules optimized to “switch” on, activating siRNA therapeutics only in selected cells -- -- CASi platform, ...

BOSTON--(BUSINESS WIRE)--Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, launched today with a Series A financing exclusively by F-Prime ...

Vivatides Therapeutics raises $54M to advance RNA therapies beyond the liver, targeting new disease areas and accelerating development.

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.